Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Statistical Tools Being Developed for Mining Cancer Data

Published: Monday, December 02, 2013
Last Updated: Monday, December 02, 2013
Bookmark and Share
Team from Rice, BCM, UT Austin tackling big data variety.

Researchers at Rice University, Baylor College of Medicine (BCM) and the University of Texas at Austin are working together to create new statistical tools that can find clues about cancer that are hidden like needles in enormous haystacks of raw data.

“The motivation for this is all of these new high-throughput medical technologies that allow clinicians to produce tons of molecular data about cancer,” said project lead Genevera Allen, a statistician with joint appointments at Rice and BCM. “For example, when a tumor is removed from a cancer patient, researchers can conduct genomic, proteomic and metabolomic scans that measure nearly every possible aspect of the tumor, including the number and location of genetic mutations and which genes are turned off and on. The end result is that for one tumor, you can have measurements on millions of variables.”

This type of data exists — the National Institutes of Health (NIH) has compiled such profiles for thousands of cancer patients — but scientists don’t yet have a way to use the data to defeat cancer.

Allen and BCM collaborator Zhandong Liu teamed up to attack the problem in 2012 thanks to a seed-funding grant from Rice’s Ken Kennedy Institute for Information Technology (K2I). Based on results of that study, Allen, Liu and UT Austin computer scientist Pradeep Ravikumar have won a new $1.3 million federal grant that will allow them to create a new statistical framework for integrated analysis of multiple sets of high-dimensional data measured on the same group of subjects.

“There are a couple of things that make this challenging,” said Allen, the principal investigator (PI) on the new grant, which was awarded jointly by the National Science Foundation and the NIH. “First, the data produced by these high-throughput technologies can be very different, so much so that you get into apples-to-oranges problems when you try in make comparisons. Second, for scientists to leverage all of this data and better understand the molecular basis of cancer, these varied ‘omics’ data sets need to be combined into a single multivariate statistical model.”

For example, Allen said, some tests, like gene-expression microarrays and methylation arrays, return “continuous data,” numbers with decimal places that represent the amounts of a particular protein or biomarker. Other tests, like RNA-sequencing, return “count data,” integers that indicate how often a biomarker shows up. And for yet other tests, the output is “binary data.” An example of this would be a test for a specific mutation that produces a zero if the mutation does not occur and a one if it does.

“Right now, the state of the art for analyzing these millions of biomarkers would be to create one data matrix — think one Excel spreadsheet — where all the numbers are continuous and can be represented with bell-shaped curves,” said Allen, Rice’s Dobelman Family Junior Chair of Statistics and assistant professor of statistics and electrical and computer engineering. “That’s very limiting for two reasons. First, for all noncontinuous variables — like the binary value related to a specific mutation — this isn’t useful. Second, we don’t want to just analyze the mutation status by itself. It’s likely that the mutation affects a bunch of these other variables, like epigenetic markers and which genes are turned on and off. Cancer is complex. It’s the result of many things coming together in a particular way. Why should we analyze each of these variables separately when we’ve got all of this data?”

Developing a framework where continuous and noncontinuous variables can be analyzed simultaneously won’t be easy. For starters, most of the techniques that statisticians have developed for parallel analysis of three or more variables — a process called multivariate analysis — only work for continuous data.

“It is a multivariate problem, and that’s how we’re approaching it,” Allen said. “But a proper multivariate distribution does not exist for this, so we have to create one mathematically.”

To do this, Allen, Liu and Ravikumar are creating a mathematical framework that will allow them to find the “conditional dependence relationships” between any two variables.

To illustrate how conditional dependence works, Allen suggested considering three variables related to childhood growth — age, IQ and shoe size. In a typical child, all three increase together.

“If we looked at a large dataset, we would see a relationship between IQ and shoe size,” she said. “In reality, there’s no direct relationship between shoe size and IQ. They happen to go up at the same time, but in reality, each of them is conditionally dependent upon age.”

For cancer genes, where the relationships aren’t as obvious, developing a mathematical technique to decipher conditional dependence could avoid the need to rule out such errors through years of expensive and time-consuming biological experiments.

Thanks to the seed-funding grant from K2I’s Collaborative Advances in Biomedical Computing program, Allen and her collaborators have already illustrated how to use these techniques. They’ve produced a network model for a half-million biomarkers related to a type of brain cancer called glioblastoma. The model acts as a sort of road map to guide researchers to the relationships that are most important in the data.

“All these lines tell us which genetic biomarkers are conditionally dependent upon one another,” she said in reference to the myriad connections in the model. “These were all determined mathematically, but our collaborators will test some of these relationships experimentally and confirm that the connections exist.”

Allen said the team’s technique will also be useful for big data challenges that exist in fields ranging from retail marketing to national security.

“This is a very general mathematical framework,” she said. “That’s why I do math. It works for everything.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cells Exercise Suboptimal Strategy to Survive
Rice University study shows it’s not always good for cells’ metabolism to work at peak efficiency.
Thursday, April 09, 2015
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos